Biblio Discovery — Demo Discovery Service

4 results for "Li-Cheng Lu"

Showing 1–4 · 0.03 seconds · RSS

  1. Journal Article

    Characteristics of HIV-positive pregnant women and HIV- and antiretroviral therapy-exposed fetuses: A case-control study

    Tung-Che Hung; Li-Cheng Lu; Mei-Hui Lin et al.

    Journal of Infection in Developing Countries, Vol. 14 No. 08 · 2020 · English · DOAJ Scopus

    Introduction: This study determined risk factors, obstetric comorbidities, and fetal conditions among HIV-positive mothers to improve their maternal care. Methodology: This retrospective case-control study included HIV-positive pregnant women 18 years of age or older and age-, parity-, and delivery…

  2. Journal Article Full text

    Compound Kushen Injection as an Adjunctive Therapy for the Treatment of Non-Small-Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials

    Pu, Liu; Chen, Wei-hao; Cao, Lu-xi et al.

    Evid Based Complement Alternat Med · 2019 · English · PubMed Central

    OBJECTIVES: To evaluate the efficacy and safety of compound Kushen injection (CKI) combined with chemo treatment (chemo) for non-small-cell lung cancer (NSCLC). METHODS: We systematically searched the literature published in seven databases, including Embase, PubMed, central, MEDLINE, CNKI…

  3. Journal Article

    Early cretaceous molybdenum-bearing felsic magmatic rocks in the tongmushan district, northern great Xing’an range: implications for mesozoic porphyry metallogenesis

    Wang Zhuo; Li Xu-Dong; Wang Jin et al.

    Frontiers in Earth Science, Vol. 14 · 2026 · English · DOAJ Scopus

    The Nenjiang-Heihe metallogenic belt of the northern Great Xing’an Range is renowned for Mesozoic epithermal Au deposits, however, apart from the Duobaoshan and Tongshan super-large porphyry deposits in the Paleozoic, no superlarge porphyry copper deposits have been discovered in the Mesozoic. The…

  4. Journal Article Full text

    Application of improved GalNAc conjugation in development of cost-effective siRNA therapies targeting cardiovascular diseases

    Li, Qian; Yin, Ke; Ma, Hai-Ping et al.

    Mol Ther · 2024 · English · PubMed Central

    N-Acetylgalactosamine (GalNAc)-conjugated small interfering RNA (siRNA) therapies have received approval for treating both orphan and prevalent diseases. To improve in vivo efficacy and streamline the chemical synthesis process for efficient and cost-effective manufacturing, we conducted this study…